Composition,Sequencing and Ion Mobility Mass Spectrometry of Heparan Sulfate-like Octasaccharide Isomers Differing in Glucuronic and Iduronic Acid Content
Restricted accessResearch articleFirst published online June, 2015
Composition,Sequencing and Ion Mobility Mass Spectrometry of Heparan Sulfate-like Octasaccharide Isomers Differing in Glucuronic and Iduronic Acid Content
Here we report ion mobility mass spectrometry (IMMS) separation and tandem mass spectrometry (MS2) sequencing methods used to analyze and differentiate six synthetically produced heparin/heparan sulfate (HS)-like octasaccharide (dp8) isomeric structures. These structures are isomeric with regard to either glucuronic acid (GlcA) or iduronic acid (IdoA) residues at various positions. IMMS analysis showed that a fully GlcA structure exhibited a more compact conformation, whereas the fully IdoA structure was more extended. Interestingly, the change from IdoA to GlcA in specific locations resulted in strong conformational distortions. MS2 of the six isomers showed very different spectra with unique sets of diagnostic product ions. Analysis of MS2 product ion spectra suggests that the GlcA group correlated with the formation of a glycosidic product ion under lower energy conditions. This resulted in an earlier product ion formation and more intense product ions. Importantly, this knowledge enabled a complete sequencing of the positions of GlcA and IdoA in each of the four positions located in each unique dp8 structure.
El-AssalO.N.RadulescuA.BesnerG.E., “Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation”, Surgery142, 234 (2007). doi: http://dx.doi.org/10.1016/j.surg.2007.04.003
2.
RocourtD.V.MehtaV.B.BesnerG.E., “Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury”, J. Surg. Res.139, 269 (2007). doi: http://dx.doi.org/10.1016/j.jss.2006.10.047
3.
LindahlU.ThunbergL.BackstromG.RiesenfeldJ., “The antithrombin-binding sequence of heparin”, Biochem. Soc. Trans.9, 499 (1981). doi: http://dx.doi.org/10.1042/bst0090499
4.
CopelandR.BalasubramaniamA.TiwariV.ZhangF.BridgesA.LinhardtR.J.ShuklaD.LiuJ., “Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of Herpes simplex virus type 1”, Biochemistry47, 5774 (2008). doi: http://dx.doi.org/10.1021/bi800205t
5.
OriA.WilkinsonM.C.FernigD.G., “The heparanome and regulation of cell function: Structures, functions and challenges”, Front. Biosci.13, 4309 (2007). doi: http://dx.doi.org/10.2741/3007
6.
KlagsbrunM., “Mediators of angiogenesis: The biological significance of basic fibroblast growth factor (BFGF)-heparin and heparan sulfate interactions”, Semin. Cancer Biol.1992, 81 (1992).
7.
SasakiT.LarssonH.KreugerJ.SalmivirtaM.Claesson–WelshL.LindahlU.HohenesterE.TimplR., “Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin”, EMBO J.18, 6240 (1999). doi: http://dx.doi.org/10.1093/emboj/18.22.6240
8.
HuZ.WangC.XiaoY.ShengN.ChenY.XuY.ZhangL.MoW.JingN.HuG., “NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development”, J. Cell Sci.122, 1145 (2009). doi: http://dx.doi.org/10.1242/jcs.034736
9.
ZhouH.RoyS.CochranE.ZouaouiR.ChuC.L.DuffnerJ.ZhaoG.SmithS.Galcheva-GargovaZ.KarlgrenJ., “M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis”, PLoS ONE6, e21106 (2011). doi: http://dx.doi.org/10.1371/journal.pone.0021106
10.
JinL.AbrahamsJ.P.SkinnerR.PetitouM.PikeR.N.CarrellR.W., “The anticoagulant activation of antithrombin by heparin”, Proc. Natl. Acad. Sci.94, 14683 (1997). doi: http://dx.doi.org/10.1073/pnas.94.26.14683
11.
PetitouM.CasuB.LindahlU., “1976–1983, a critical period in the history of heparin: The discovery of the antithrombin binding site”, Biochimie85, 83 (2003). doi: http://dx.doi.org/10.1016/S0300-9084(03)00078-6
12.
BameK.J.VenkatesanI.StellingH.D.TumovaS., “The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases”, Glycobiology10, 715 (2000). doi: http://dx.doi.org/10.1093/glycob/10.7.715
13.
LyonM.GallagherJ.T., “Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion”, Matrix Biol.17, 485 (1998). doi: http://dx.doi.org/10.1016/S0945-053X(98)90096-8
14.
AthaD.H.LormeauJ.C.PetitouM.RosenbergR.D.ChoayJ., “Contribution of monosaccharide residues in heparin binding to antithrombin III”, Biochemistry24, 6723 (1985). doi: http://dx.doi.org/10.1021/bi00344a063
15.
LindahlU.BäckströmG.ThunbergL., “The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group”, J. Biol. Chem.258, 9826 (1983).
16.
LindahlU.BäckströmG.ThunbergL.LederI.G., “Evidence for a 3-O-sulfated d-glucosamine residue in the antithrombin-binding sequence of heparin”, Proc. Natl. Acad. Sci.77, 6551 (1980). doi: http://dx.doi.org/10.1073/pnas.77.11.6551
17.
PetitouM.DuchaussoyP.LedermanI.ChoayJ.SinaÿP., “Binding of heparin to antithrombin III: A chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-d-glucose residue”, Carbohydr. Res.179, 163 (1988). doi: http://dx.doi.org/10.1016/0008-6215(88)84116-8
18.
RiesenfeldJ.ThunbergL.HöökM.LindahlU., “The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups”, J. Biol. Chem.256, 2389 (1981).
19.
MerryC.L.LyonM.DeakinJ.A.HopwoodJ.J.GallagherJ.T., “Highly sensitive sequencing of the sulfated domains of heparan sulfate”, J. Biol. Chem.274, 18455 (1999). doi: http://dx.doi.org/10.1074/jbc.274.26.18455
20.
SaadO.M.EbelH.UchimuraK.RosenS.D.BertozziC.R.LearyJ.A., “Compositional profiling of heparin/heparan sulfate using mass spectrometry: Assay for specificity of a novel extracellular human endosulfatase”, Glycobiology15, 818 (2005). doi: http://dx.doi.org/10.1093/glycob/cwi064
21.
SaadO.M.LearyJ.A., “Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry”, Anal. Chem.75, 2985 (2003). doi: http://dx.doi.org/10.1021/ac0340455
22.
SaadO.M.LearyJ.A., “Delineating mechanisms of dissociation for isomeric heparin disaccharides using isotope labeling and ion trap tandem mass spectrometry”, J. Am. Soc. Mass Spectrom.15, 1274 (2004). doi: http://dx.doi.org/10.1016/j.jasms.2004.05.008
23.
SaadO.M.LearyJ.A., “Heparin sequencing using enzymatic digestion and ESI-MSn with host: A heparin/HS oligosaccharide sequencing tool”, Anal. Chem.77, 5902 (2005). doi: http://dx.doi.org/10.1021/ac050793d
24.
SchenauerM.R.MeissenJ.K.SeoY.AmesJ.B.LearyJ.A., “Heparan sulfate separation, sequencing, and isomeric differentiation: Ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides”, Anal. Chem.81, 10179 (2009). doi: http://dx.doi.org/10.1021/ac902186h
25.
SeoY.AndayaA.LearyJ.A., “Preparation, separation, and conformational analysis of differentially sulfated heparin octasaccharide isomers using ion mobility mass spectrometry”, Anal. Chem.84, 2416 (2012). doi: http://dx.doi.org/10.1021/ac203190k
26.
VivesR.PyeD.SalmivirtaM.HopwoodJ.LindahlU.GallagherJ., “Sequence analysis of heparan sulphate and heparin oligosaccharides”, Biochem. J.339, 767 (1999). doi: http://dx.doi.org/10.1042/0264-6021:3390767
27.
TurnbullJ.E.HopwoodJ.J.GallagherJ.T., “A strategy for rapid sequencing of heparan sulfate and heparin saccharides”, Proc. Natl. Acad. Sci.96, 2698 (1999). doi: http://dx.doi.org/10.1073/pnas.96.6.2698
HricovíniM.TorriG., “Dynamics in aqueous solutions of the pentasaccharide corresponding to the binding site of heparin for antithrombin III studied by NMR relaxation measurements”, Carbohydr. Res.268, 159 (1995). doi: http://dx.doi.org/10.1016/0008-6215(94)00334-C
30.
LeachF.E.IIIArungundramS.Al-MafrajiK.VenotA.BoonsG.-J.AmsterI.J., “Electron detachment dissociation of synthetic heparan sulfate glycosaminoglycan tetrasaccharides varying in degree of sulfation and hexuronic acid stereochemistry”, Int. J. Mass Spectrom.330, 152 (2012). doi: http://dx.doi.org/10.1016/j.ijms.2012.07.002
OhH.B.LeachF.E.IIIArungundramS.Al-MafrajiK.VenotA.BoonsG.-J.AmsterI.J., “Multivariate analysis of electron detachment dissociation and infrared multiphoton dissociation mass spectra of heparan sulfate tetrasaccharides differing only in hexuronic acid stereochemistry”, J. Am. Soc. Mass Spectrom.22, 582 (2011). doi: http://dx.doi.org/10.1007/s13361-010-0047-y
33.
WolffJ.J.ChiL.LinhardtR.J.AmsterI.J., “Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachment dissociation”, Anal. Chem.79, 2015 (2007). doi: http://dx.doi.org/10.1021/ac061636x
34.
LeachF.E.IIIWolffJ.J.XiaoZ.LyM.LaremoreT.N.ArungundramS.Al-MafrajiK.VenotA.BoonsG.-J.LinhardtR.J., “Negative electron transfer dissociation Fourier transform mass spectrometry of glycosaminoglycan carbohydrates”, Eur. J. Mass Spectrom.17, 167 (2011). doi: http://dx.doi.org/10.1255/ejms.1120
35.
WolffJ.J.LeachF.E.IIILaremoreT.N.KaplanD.A.EasterlingM.L.LinhardtR.J.AmsterI.J., “Negative electron transfer dissociation of glycosaminoglycans”, Anal. Chem.82, 3460 (2010). doi: http://dx.doi.org/10.1021/ac100554a
36.
WolffJ.J.AmsterI.J.ChiL.LinhardtR.J., “Electron detachment dissociation of glycosaminoglycan tetrasaccharides”, J. Am. Soc. Mass Spectrom.18, 234 (2007). doi: http://dx.doi.org/10.1016/j.jasms.2006.09.020
37.
WolffJ.J.LaremoreT.N.BuschA.M.LinhardtR.J.AmsterI.J., “Electron detachment dissociation of dermatan sulfate oligosaccharides”, J. Am. Soc. Mass Spectrom.19, 294 (2008). doi: http://dx.doi.org/10.1016/j.jasms.2007.10.007
38.
WolffJ.J.LaremoreT.N.AslamH.LinhardtR.J.AmsterI.J., “Electron-induced dissociation of glycosaminoglycan tetrasaccharides”, J. Am. Soc. Mass Spectrom.19, 1449 (2008). doi: http://dx.doi.org/10.1016/j.jasms.2008.06.024
39.
AtkinsE.LaurentT., “X-ray diffraction patterns from chondroitin 4-sulphate, dermatan sulphate and heparan sulphate”, Biochem. J.133, 605 (1973).
40.
FerroD.R.ProvasoliA.RagazziM.CasuB.TorriG.BossennecV.PerlyB.SinaÿP.PetitouM.ChoayJ., “Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences”, Carbohydr. Res.195, 157 (1990). doi: http://dx.doi.org/10.1016/0008-6215(90)84164-P
41.
SandersonP.N.HuckerbyT.N.NieduszynskiI.A., “Conformational equilibria of alpha-l-iduronate residues in disaccharides derived from heparin”, Biochem. J.243, 175 (1987).
42.
YatesE.A.SantiniF.GuerriniM.NaggiA.TorriG.CasuB., “1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives”, Carbohydr. Res.294, 15 (1996). doi: http://dx.doi.org/10.1016/S0008-6215(96)90611-4
43.
SeoY.AndayaA.BleiholderC.LearyJ.A., “Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: An ion mobility mass spectrometry approach”, J. Am. Chem. Soc.135, 4325 (2013). doi: http://dx.doi.org/10.1021/ja310915m
44.
SeoY.SchenauerM.R.LearyJ.A., “Biologically relevant metal-cation binding induces conformational changes in heparin oligosaccharides as measured by ion mobility mass spectrometry”, Int. J. Mass Spectrom.303, 191 (2011). doi: http://dx.doi.org/10.1016/j.ijms.2011.02.003
45.
UjmaJ.De CeccoM.ChepelinO.LeveneH.MoffatC.PikeS.J.LusbyP.J.BarranP.E., “Shapes of supra-molecular cages by ion mobility mass spectrometry”, Chem. Commun.48, 4423 (2012). doi: http://dx.doi.org/10.1039/C2CC30778B
46.
JinL.BarranP.E.DeakinJ.A.LyonM.UhrínD., “Conformation of glycosaminoglycans by ion mobility mass spectrometry and molecular modelling”, Phys. Chem. Chem. Phys.7, 3464 (2005). doi: http://dx.doi.org/10.1039/B508644B
47.
JurneczkoE.KalapothakisJ.CampuzanoI.D.MorrisM.BarranP.E., “Effects of drift gas on collision cross sections of a protein standard in linear drift tube and traveling wave ion mobility mass spectrometry”, Anal. Chem.84, 8524 (2012). doi: http://dx.doi.org/10.1021/ac301260d
48.
SchwörerR.ZubkovaO.V.TurnbullJ.E.TylerP.C., “Synthesis of a targeted library of heparan sulfate hexaβ- to dodecasaccharides as inhibitors of β-secretase: Potential therapeutics for Alzheimer's disease”, Chem. Eur. J.19, 6817 (2013). doi: http://dx.doi.org/10.1002/chem.201204519
49.
DomonB.CostelloC.E., “Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry”, Biochemistry27, 1534 (1988). doi: http://dx.doi.org/10.1021/bi00405a021
